Imagine a world where antibiotics are so precisely targeted that they only attack harmful bacteria, leaving beneficial microorganisms unharmed and reducing the risk of antibiotic resistance. This scenario may not be as far-fetched as it seems, thanks to the pioneering work of researchers at the
January 15, 2025Osteosarcoma, a rare and aggressive bone cancer, primarily affects children and young adults during periods of rapid bone growth. Despite its rarity, the impact of osteosarcoma is devastating, often requiring surgery or amputation and posing a high risk of metastasis to the lungs. For decades, the
January 15, 2025The field of oncology has witnessed numerous advancements over the years, but the introduction of molecular glue degraders marks a significant leap forward. These innovative small molecules are poised to transform cancer treatment by targeting previously "undruggable" proteins, offering
January 15, 2025The transformative impact of rapid in-house next-generation sequencing (NGS) technology on cancer treatment is becoming increasingly evident. This advancement is particularly significant in enabling personalized medicine and improving patient outcomes. With the progress in molecular testing and the
January 15, 2025In a groundbreaking study, researchers have introduced a non-invasive method to predict stroke risk using a 'vascular fingerprint' identified in the retina, suggesting revolutionary potential for medical diagnostics. The method is detailed in the journal Heart, demonstrating that retinal
January 14, 2025Imagine a world where getting vaccinated no longer means facing a needle and syringe, but instead, involves a simple patch applied to the skin. This prospect is rapidly becoming a reality thanks to the innovative work of the University of Queensland (UQ) and Brisbane-based biotech company Vaxxas.
January 14, 2025